ATYR FY 2017 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$89M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$713,000

Operating Income

-$47M

Net Income

-$48M

EPS (Diluted)

$-26.16

Cash Flow

Operating Cash Flow

-$42M

Free Cash Flow

-$44M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$89M

Total Liabilities

$25M

Stockholders' Equity

$64M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$713,000	-$900,000	+20.8%
Operating Income	-$47M	-$59M	+20.6%
Net Income	-$48M	-$58M	+16.7%